These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16982058)

  • 1. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
    Higashi Y; Miyazaki M; Goto C; Sanada H; Sueda T; Chayama K
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia.
    Higashi Y; Kimura M; Hara K; Noma K; Jitsuiki D; Nakagawa K; Oshima T; Chayama K; Sueda T; Goto C; Matsubara H; Murohara T; Yoshizumi M
    Circulation; 2004 Mar; 109(10):1215-8. PubMed ID: 15007007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
    Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
    Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
    Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
    Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Augmentation of revascularization by implantation of autologous bone marrow mononuclear cells in a rat ischemic hind limb model].
    Liu WL; Yin BL; Yu FL; Hu YR; Chen XF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):572-6. PubMed ID: 16137050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
    Capiod JC; Tournois C; Vitry F; Sevestre MA; Daliphard S; Reix T; Nguyen P; Lefrère JJ; Pignon B
    Vox Sang; 2009 Apr; 96(3):256-65. PubMed ID: 19207166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R; Petriczek T; Skotnicki A; Szczeklik A
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
    Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
    Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia　- The SCELTA Trial.
    Liotta F; Annunziato F; Castellani S; Boddi M; Alterini B; Castellini G; Mazzanti B; Cosmi L; Acquafresca M; Bartalesi F; Dilaghi B; Dorigo W; Graziani G; Bartolozzi B; Bellandi G; Carli G; Bartoloni A; Fargion A; Fassio F; Fontanari P; Landini G; Lucente EAM; Michelagnoli S; Orsi Battaglini C; Panigada G; Pigozzi C; Querci V; Santarlasci V; Parronchi P; Troisi N; Baggiore C; Romagnani P; Mannucci E; Saccardi R; Pratesi C; Gensini G; Romagnani S; Maggi E
    Circ J; 2018 May; 82(6):1688-1698. PubMed ID: 29576595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: a pilot study.
    Koshikawa M; Shimodaira S; Yoshioka T; Kasai H; Watanabe N; Wada Y; Seto T; Fukui D; Amano J; Ikeda U
    Curr Med Res Opin; 2006 Apr; 22(4):793-8. PubMed ID: 16684440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.